Get the Stockscreener App
1.45
1.40%
0.02
Compugen Ltd stock is traded at $1.45, with a volume of 150.81K.
It is up +1.40% in the last 24 hours and down -6.45% over the past month.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
See More
Previous Close:
$1.43
Open:
$1.42
24h Volume:
150.81K
Relative Volume:
0.66
Market Cap:
$144.98M
Revenue:
-
Net Income/Loss:
$1.60M
P/E Ratio:
48.33
EPS:
0.03
Net Cash Flow:
$-62.91M
1W Performance:
+1.40%
1M Performance:
-6.45%
6M Performance:
-30.95%
1Y Performance:
-28.92%
1-Day Range:
$1.42
$1.50
1-Week Range:
$1.4037
$1.56
52-Week Range:
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.45 | 144.98M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-25 | Initiated | Oppenheimer | Outperform |
| Aug-05-22 | Downgrade | Jefferies | Buy → Hold |
| May-26-20 | Resumed | JMP Securities | Mkt Outperform |
| May-13-20 | Initiated | Stifel | Buy |
| May-07-20 | Initiated | SVB Leerink | Outperform |
| Apr-22-20 | Initiated | ROTH Capital | Buy |
| Mar-24-20 | Initiated | SunTrust | Buy |
| Jan-16-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-29-18 | Initiated | Oppenheimer | Outperform |
| Feb-01-16 | Resumed | Oppenheimer | Outperform |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Apr-23-15 | Resumed | Jefferies | Buy |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Feb-07-14 | Initiated | MLV & Co | Buy |
| Dec-28-09 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-29-09 | Initiated | Cantor Fitzgerald | Buy |
View All
Compugen Ltd Stock (CGEN) Latest News
Compugen Ltd. At Decision Level — Rebound or ResistanceJuly 2025 Catalysts & Risk Managed Trade Strategies - classian.co.kr
Pattern recognition hints at Compugen Ltd. upsideOptions Play & Safe Capital Investment Plans - Newser
What data driven models say about Compugen Ltd.’s future2025 Year in Review & Consistent Profit Focused Trading Strategies - Newser
Should you wait for a breakout in Compugen Ltd.2025 Geopolitical Influence & Risk Controlled Daily Trade Plans - Newser
Can a trend reversal in Compugen Ltd. lead to recoveryJuly 2025 Setups & AI Forecast Swing Trade Picks - Newser
Will Compugen Ltd. Stock Benefit from AI and Green Energy TrendsLong Setup & Reliable Intraday Trade Alerts - Newser
Advanced analytics toolkit walkthrough for Compugen Ltd.Market Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
Statistical indicators supporting Compugen Ltd.’s strength2025 Investor Takeaways & Real-Time Sentiment Analysis - Newser
Compugen Ltd. stock prediction for this weekTrade Ideas & Fast Moving Trade Plans - Newser
Analyzing net buyer seller activity in Compugen Ltd.Portfolio Risk Report & Free Technical Pattern Based Buy Signals - Newser
How to forecast Compugen Ltd. trends using time seriesCPI Data & Comprehensive Market Scan Insights - Newser
Real time pattern detection on Compugen Ltd. stock2025 Price Action Summary & High Conviction Investment Ideas - Newser
Why Compugen Ltd. stock attracts strong analyst attention2025 Key Highlights & Free Real-Time Volume Trigger Notifications - Newser
Real time scanner hits for Compugen Ltd. explained2025 Historical Comparison & Advanced Swing Trade Entry Plans - Newser
Historical volatility pattern of Compugen Ltd. visualizedTrade Analysis Report & Expert Verified Stock Movement Alerts - Newser
Can Compugen Ltd. hit a new high this monthMarket Sentiment Report & Low Risk Profit Maximizing Plans - Newser
Applying chart zones and confluence areas to Compugen Ltd.Weekly Gains Summary & High Return Trade Opportunity Guides - Newser
Using Bollinger Bands to evaluate Compugen Ltd.Market Volume Report & Detailed Earnings Play Strategies - Newser
Compugen Ltd. recovery potential after sell offJuly 2025 Pullbacks & Weekly Market Pulse Updates - Newser
Is Compugen Ltd. stock entering bullish territoryGlobal Markets & Daily Price Action Insights - Newser
What earnings revisions data tells us about Compugen Ltd.Portfolio Performance Report & Long Hold Capital Preservation Plans - Newser
Compugen Ltd. stock retracement – recovery analysisIndex Update & Advanced Swing Trade Entry Plans - Newser
How Efficient Is Compugen Ltd. at Controlling Operating Costs2025 Valuation Update & High Conviction Buy Zone Alerts - Newser
Using data tools to time your Compugen Ltd. exitInsider Selling & High Win Rate Trade Tips - Newser
Intrinsic Value of Compugen Ltd. Stock: Is It Undervalued or OvervaluedOptions Play & Consistent Profit Focused Trading Strategies - Newser
How to read the order book for Compugen Ltd.Wall Street Watch & Technical Entry and Exit Alerts - Newser
Compugen Ltd Stock (CGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):